Cabazitaxel for metastatic castration-resistant prostate cancer: safety data from the Spanish expanded access programCASTELLANO, Daniel; ANTON APARICIO, Luis M; ESTEBAN, Emilio et al.Expert opinion on drug safety. 2014, Vol 13, Num 9, pp 1165-1173, issn 1474-0338, 9 p.Article

Cardiac concerns associated with strontium ranelateREGINSTER, Jean-Yves.Expert opinion on drug safety. 2014, Vol 13, Num 9, pp 1209-1213, issn 1474-0338, 5 p.Article

Cardiac safety concerns for domperidone, an antiemetic and prokinetic, and galactogogue medicineDOGGRELL, Sheila A; HANCOX, Jules C.Expert opinion on drug safety. 2014, Vol 13, Num 1, pp 131-138, issn 1474-0338, 8 p.Article

Cardiac toxicity of some echinocandin antifungalsSTOVER, Kayla R; FARLEY, Jerry M; KYLE, Patrick B et al.Expert opinion on drug safety. 2014, Vol 13, Num 1, pp 5-14, issn 1474-0338, 10 p.Article

Current therapies for the treatment of systemic sclerosis-related pulmonary arterial hypertension: efficacy and safetyMURDACA, Giuseppe; SPANO, Francesca; PUPPO, Francesco et al.Expert opinion on drug safety. 2014, Vol 13, Num 3, pp 295-305, issn 1474-0338, 11 p.Article

Does long-term aspirin use increase the risk of neovascular age-related macular degeneration?CHRISTEN, William G; CHEW, Emily Y.Expert opinion on drug safety. 2014, Vol 13, Num 4, pp 421-429, issn 1474-0338, 9 p.Article

Drug safety evaluation of naltrexone/bupropion for the treatment of obesityVERPEUT, Jessica L; BELLO, Nicholas T.Expert opinion on drug safety. 2014, Vol 13, Num 6, pp 831-841, issn 1474-0338, 11 p.Article

Immune reconstitution inflammatory syndrome associated with bacterial infectionsLAGIER, Jean-Christophe; RAOULT, Didier.Expert opinion on drug safety. 2014, Vol 13, Num 3, pp 341-350, issn 1474-0338, 10 p.Article

Prospects for MEK inhibitors for treating cancerMARTIN-LIBERAL, Juan; LAGARES-TENA, Laura; LARKIN, James et al.Expert opinion on drug safety. 2014, Vol 13, Num 4, pp 483-495, issn 1474-0338, 13 p.Article

Safety of sublingual immunotherapy in childrenFRATI, Franco; RIDOLO, Erminia; FUIANO, Nicola et al.Expert opinion on drug safety. 2014, Vol 13, Num 7, pp 947-953, issn 1474-0338, 7 p.Article

Statin use and the risk of breast cancer: a population-based case-control studyCHAN, Te-Fu; WU, Chen-Hsuan; LIN, Chih-Lung et al.Expert opinion on drug safety. 2014, Vol 13, Num 3, pp 287-293, issn 1474-0338, 7 p.Article

The safety of novel drugs used to treat irritable bowel syndromeMOZAFFARI, Shilan; NIKFAR, Shekoufeh; ABDOLLAHI, Mohammad et al.Expert opinion on drug safety. 2014, Vol 13, Num 5, pp 625-638, issn 1474-0338, 14 p.Article

Efficacy of antidepressant medications in children and adolescents with non-obsessive-compulsive disorder anxiety disorders: a systematic assessmentGENTILE, Salvatore.Expert opinion on drug safety. 2014, Vol 13, Num 6, pp 735-744, issn 1474-0338, 10 p.Article

Cancer immunotherapies, their safety and toxicityALATRASH, Gheath; JAKHER, Haroon; STAFFORD, Patricia D et al.Expert opinion on drug safety. 2013, Vol 12, Num 5, pp 631-645, issn 1474-0338, 15 p.Article

Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLCADDEO, Raffaele; ZAPPAVIGNA, Silvia; LUCE, Amalia et al.Expert opinion on drug safety. 2013, Vol 12, Num 5, pp 729-740, issn 1474-0338, 12 p.Article

Drug-induced parkinsonismLÓPEZ-SENDÓN, José; MENA, Maria A; DE YÉBENES, Justo G et al.Expert opinion on drug safety. 2013, Vol 12, Num 4, pp 487-496, issn 1474-0338, 10 p.Article

Gliptins (dipeptidyl peptidase-4 inhibitors) and risk of acute pancreatitisSCHEEN, Andre.Expert opinion on drug safety. 2013, Vol 12, Num 4, pp 545-557, issn 1474-0338, 13 p.Article

Lenalidomide and thalidomide in the treatment of chronic painASHER, Christopher; FURNISH, Timothy.Expert opinion on drug safety. 2013, Vol 12, Num 3, pp 367-374, issn 1474-0338, 8 p.Article

Oxycodone combined with opioid receptor antagonists: efficacy and safetyDAVIS, Mellar; GOFORTH, Harold W; GAMIER, Pam et al.Expert opinion on drug safety. 2013, Vol 12, Num 3, pp 389-402, issn 1474-0338, 14 p.Article

Safety and tolerability of paricalcitol in patients with chronic kidney diseaseDYER, Christopher A.Expert opinion on drug safety. 2013, Vol 12, Num 5, pp 717-728, issn 1474-0338, 12 p.Article

Safety concerns with the long-term management of osteoporosisREGINSTER, Jean-Yves; PELOUSSE, Franz; BRUYÈRE, Olivier et al.Expert opinion on drug safety. 2013, Vol 12, Num 4, pp 507-522, issn 1474-0338, 16 p.Article

Safety of celecoxib compared with placebo and non-selective NSAIDs: cumulative meta-analysis of 89 randomized controlled trialsNOYES ESSEX, Margaret; ZHANG, Richard Y; BERGER, Manuela F et al.Expert opinion on drug safety. 2013, Vol 12, Num 4, pp 465-477, issn 1474-0338, 13 p.Article

Drug safety evaluation of olanzapine pamoateSCHÖTTLE, Daniel; KUHNIGK, Olaf; NABER, Dieter et al.Expert opinion on drug safety. 2013, Vol 12, Num 6, pp 897-903, issn 1474-0338, 7 p.Article

A systematic review of the safety of probioticsDIDARI, Tina; SOLKI, Sara; MOZAFFARI, Shilan et al.Expert opinion on drug safety. 2014, Vol 13, Num 2, pp 227-239, issn 1474-0338, 13 p.Article

Acute mycophenolate overdose: case series and systematic literature analysisCESCHI, Alessandro; GREGORIANO, Claudia; RAUBER-LÜTHY, Christine et al.Expert opinion on drug safety. 2014, Vol 13, Num 5, pp 525-534, issn 1474-0338, 10 p.Article